Nahdi Medical Company (4164.SR)
SAR 114.2
(-0.17%)
SAR 114.2
(-0.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.4 Billion SAR | 19.16% |
| 2022 | 1.18 Billion SAR | 5.94% |
| 2021 | 1.11 Billion SAR | -8.51% |
| 2020 | 1.22 Billion SAR | 1.43% |
| 2019 | 1.2 Billion SAR | 1.6% |
| 2018 | 1.18 Billion SAR | -5.11% |
| 2017 | 1.24 Billion SAR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.7 Billion SAR | -2.93% |
| 2024 Q1 | 1.76 Billion SAR | 24.94% |
| 2023 Q2 | 1.39 Billion SAR | 0.52% |
| 2023 Q1 | 1.38 Billion SAR | 17.08% |
| 2023 FY | 1.4 Billion SAR | 19.16% |
| 2023 Q4 | 1.4 Billion SAR | 5.2% |
| 2023 Q3 | 1.33 Billion SAR | -3.77% |
| 2022 Q4 | 1.18 Billion SAR | -6.92% |
| 2022 Q3 | 1.27 Billion SAR | -2.04% |
| 2022 Q2 | 1.29 Billion SAR | -1.73% |
| 2022 Q1 | 1.32 Billion SAR | 18.23% |
| 2022 FY | 1.18 Billion SAR | 5.94% |
| 2021 FY | 1.11 Billion SAR | -8.51% |
| 2021 Q3 | 1.17 Billion SAR | 2.63% |
| 2021 Q2 | 1.14 Billion SAR | 0.0% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 Q4 | 1.11 Billion SAR | -5.08% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 FY | 1.22 Billion SAR | 1.43% |
| 2020 Q4 | 1.14 Billion SAR | 0.0% |
| 2019 FY | 1.2 Billion SAR | 1.6% |
| 2018 FY | 1.18 Billion SAR | -5.11% |
| 2017 FY | 1.24 Billion SAR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 87.17 Million SAR | -1516.845% |
| Al-Dawaa Medical Services Company | 1.3 Billion SAR | -7.616% |
| Al-Razi Medical Co. | 22.81 Million SAR | -6077.636% |
| Almujtama Alraida Medical Co. | 143.32 Million SAR | -883.395% |